Medicines Co. (MDCO) Misses Q4 EPS by 1c

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($0.62), $0.01 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $0 , versus $8.6 million reported last year.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Goldman Sachs Starts Viridien (VIRI:FP) at Buy
• Citi raises Atlassian price target to $225, maintains Buy rating